SlideShare a Scribd company logo
By…
Mr. S. L. Khan
M. Pharm(PhD),
Assistant Professor,
Pharmaceutical Chemistry,
Rajarshi Shahu College of Pharmacy,
Buldhana, Maharashtra
Subscribe to the YouTube Channel #Professor_BeuBenz
https://www.youtube.com/channel/UC84jGf2iRN5VjwnQqi6qmXg?view_as=subscriber
Copyright © 2018 Professor BeuBenz
INTRODUCTION
Pharmacopoeia: the word derives from the ancient Greek word
Pharmakon means Drug & Poeia means to make.
It is a legally binding collection, prepared by a national or regional authority &
contains list of medicinal substances, crude drug & formulas for making
preparation from them.
The pharmacopoeia contain-:
 List of drug and other related substances
 Sources
 Description
 Tests
 Formulas for preparation actions
 Uses
 Doses
 Storage conditions
Copyright © 2018 Professor BeuBenz
 National Pharmacopoeia(s):
United States Pharmacopoeia (USP),
Indian Pharmacopeia(IP),
Pharmacopoeia of the People's Republic of China(PPRC),
German Pharmacopeia,
British Pharmacopoeia (BP),
Portugese Pharmacopoeia,
Mexican Pharmacopoeia,
French Pharmacopoeia,
Japanese Pharmacopoeia (JP) and
Argentinean Pharmacopoeia
 Regional Pharmacopoeia(s):
 European Pharmacopoeia.
 International Pharmacopoeia(s):
 International Pharmacopoeia.
Different Types of
Pharmacopoeia
Copyright © 2018 Professor BeuBenz
INDIAN PHARMACOPOEIA
 Indian Pharmacopoeia Commission (IPC) is an autonomous
institution of the Ministry of Health and Family Welfare which sets
standards for all drugs that are manufactured, sold and consumed in India
The set of standards are published under the title Indian
Pharmacopoeia (IP)
Vision: The IPC is committed to the promotion of the highest standards for
drugs for use in the prevention and treatment of diseases in human beings
and animals keeping in view the special features of the pharmaceutical
industry in India.
Objectives…?
Copyright © 2018 Professor BeuBenz
HISTORY & EDITIONS
The process of publishing the first Pharmacopoeia started in the year 1944 under
the chairmanship of R. N. Chopra
• In 1948 government of India appointed an Indian Pharmacopeia committee to prepare
‘Pharmacopeia of India’
• 1st edition I. P. 1955 was published in the official gazette. Dr. B. N. Ghosh, Chairman
– Supplement 1960
• 2nd edition I. P. 1966, Dr. B. Mukherji, Chairman, Shankar S.
– Supplement 1975
• 3rd edition I. P. 1985, Dr. Nityanand, Chairman
– I Addendum/Supplement 1989
– II Addendum/Supplement 1991
Copyright © 2018 Professor BeuBenz
• 4th Edition I. P. 1996 Dr. Nityanand, Chairman
– III Addendum/ Supplement 2000
– IV Addendum/ Supplement 2002
• 5th Edition I. P., 2007, Dr. Nityanand, Chairman
• 6th Edition I. P., 2010
• 7th Edition I. P. 2014
-- V Addendum/Supplement 2015
• 8th Edition I. P. 2018
-- IV Volumes
HISTORY & EDITIONS
Copyright © 2018 Professor BeuBenz
 The Indian Pharmacopoeia is the official book of standards and
medicines produced in India must comply with the specified standards
 Pharmacopoeial standards and acceptance criteria are set with the
intention that they be used only as compliance requirements and not as
requirements to guarantee total quality assurance
 Pharmacopoeial standards are the minimum ones with which a
manufacturer must comply before release of a product for sale or
distribution
 It is recognized that changes in quality may occur during storage and
distribution and the pharmacopoeial requirements are set to define
acceptable levels of change and to reject materials or products showing
unacceptable levels
OVERALL PHILOSOPHY
Copyright © 2018 Professor BeuBenz
It is the responsibility of the manufacturer to ensure that the product is
manufactured in accordance with current Good Manufacturing Practices and that
sufficiently stringent limits of acceptance are applied at the time of release of a
batch of material or product so that the compendial standards are met until the
expiry date under the storage conditions specified
Pharmacopoeial requirements for drug substances have been drawn up to provide
appropriate limits for potential impurities rather than to provide against all possible
impurities and adulterants
Material found to contain an impurity that cannot be detected by means of the
prescribed tests is to be considered as not of pharmacopoeial quality if the nature or
amount of the impurity found is not compatible with good manufacturing practices
Copyright © 2018 Professor BeuBenz
INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT
Normal Format
 Description. Physical form of the material, whether hygroscopic, odour, if
apparent and indication of polymorphism, if applicable
 Identification Tests usually including infrared spectrometry, if appropriate
 Non-specific purity tests, such as light absorption, optical rotation, sulphated
ash etc
 Impurities , both related substances and impurities that may be present as a
result of the method of manufacture or from degradation on storage
 Impurities other than related substances that may require control such as
heavy metals, inorganic impurities, residues of solvents and reagents used
during synthesis and purification
Copyright © 2018 Professor BeuBenz
Other tests such as loss on drying or water
Assay and limits for purity calculated on the anhydrous, dried or solvent-free
basis, as appropriate
To the extent possible, for assay, a robust and precise, though not specific
method is given rather than a specific stability-indicating and complex one. With
increasing emphasis on stability, the latter is often unavoidable
In the case of non-specific assay methods, control of impurities is provided
separately by means of specific impurity tests
Each monograph is designed to be considered as a whole and should provide a
reliable basis for judging the quality of the drug substance
INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT
Copyright © 2018 Professor BeuBenz

More Related Content

What's hot

Sources of impurities
Sources of impuritiesSources of impurities
Sources of impurities
Revathi Gnanavelou
 
Sources and types of impurities
Sources and types of impuritiesSources and types of impurities
Sources and types of impurities
jagan vana
 
Limit test
Limit testLimit test
Limit test
Revathi Gnanavelou
 
pharmacopoeia and monograph, pharmaceutical inorganic chemistry
pharmacopoeia and monograph, pharmaceutical inorganic chemistrypharmacopoeia and monograph, pharmaceutical inorganic chemistry
pharmacopoeia and monograph, pharmaceutical inorganic chemistry
nehla313
 
Modified limit tests for chlorides and sulphates.
Modified limit tests for chlorides and sulphates.Modified limit tests for chlorides and sulphates.
Modified limit tests for chlorides and sulphates.
EXCELRA
 
History of pharmacopoeia 1
History of pharmacopoeia 1History of pharmacopoeia 1
History of pharmacopoeia 1
SRMUBarabanki
 
Impurities in Pharmaceutical Substances
Impurities in Pharmaceutical SubstancesImpurities in Pharmaceutical Substances
Impurities in Pharmaceutical Substances
Dhiraj Nikam
 
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRYUnit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Sayali Powar
 
Limit Tests ppt
Limit Tests pptLimit Tests ppt
Limit Tests ppt
Aditya Sharma
 
Limit test for chloride
Limit test for chlorideLimit test for chloride
Limit test for chloride
DR.Gopinathan Narasimhan
 
Introduction to pharmaceutical Inorganic Chemistry
Introduction to pharmaceutical Inorganic ChemistryIntroduction to pharmaceutical Inorganic Chemistry
Introduction to pharmaceutical Inorganic Chemistry
Ashish Chaudhari
 
limit test for lead
limit test for leadlimit test for lead
limit test for lead
TAUFIK MULLA
 
Assay of calcium gluconate
Assay of calcium gluconateAssay of calcium gluconate
Assay of calcium gluconate
smita shelke
 
Neutralization curves in acid base analytical titrations, indicators.
Neutralization curves in acid base analytical titrations, indicators.Neutralization curves in acid base analytical titrations, indicators.
Neutralization curves in acid base analytical titrations, indicators.
nehla313
 
Analysis
AnalysisAnalysis
Analysis
meraj khan
 
Limit test for arsenic and lead
Limit test for arsenic and leadLimit test for arsenic and lead
Limit test for arsenic and lead
Ashish Chaudhari
 
Anti dote
Anti doteAnti dote
Different Techniques of Pharmaceutical Analysis
Different Techniques of Pharmaceutical AnalysisDifferent Techniques of Pharmaceutical Analysis
Different Techniques of Pharmaceutical Analysis
Sapan Shah
 
UNIT I_History of pharmacopoeia and limit test
UNIT I_History of pharmacopoeia and limit testUNIT I_History of pharmacopoeia and limit test
UNIT I_History of pharmacopoeia and limit test
SONALI PAWAR
 
3.limit test for sulphate
3.limit test for sulphate3.limit test for sulphate
3.limit test for sulphate
DR.Gopinathan Narasimhan
 

What's hot (20)

Sources of impurities
Sources of impuritiesSources of impurities
Sources of impurities
 
Sources and types of impurities
Sources and types of impuritiesSources and types of impurities
Sources and types of impurities
 
Limit test
Limit testLimit test
Limit test
 
pharmacopoeia and monograph, pharmaceutical inorganic chemistry
pharmacopoeia and monograph, pharmaceutical inorganic chemistrypharmacopoeia and monograph, pharmaceutical inorganic chemistry
pharmacopoeia and monograph, pharmaceutical inorganic chemistry
 
Modified limit tests for chlorides and sulphates.
Modified limit tests for chlorides and sulphates.Modified limit tests for chlorides and sulphates.
Modified limit tests for chlorides and sulphates.
 
History of pharmacopoeia 1
History of pharmacopoeia 1History of pharmacopoeia 1
History of pharmacopoeia 1
 
Impurities in Pharmaceutical Substances
Impurities in Pharmaceutical SubstancesImpurities in Pharmaceutical Substances
Impurities in Pharmaceutical Substances
 
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRYUnit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
Unit 1 PHARMACEUTICAL INORGANIC CHEMISTRY
 
Limit Tests ppt
Limit Tests pptLimit Tests ppt
Limit Tests ppt
 
Limit test for chloride
Limit test for chlorideLimit test for chloride
Limit test for chloride
 
Introduction to pharmaceutical Inorganic Chemistry
Introduction to pharmaceutical Inorganic ChemistryIntroduction to pharmaceutical Inorganic Chemistry
Introduction to pharmaceutical Inorganic Chemistry
 
limit test for lead
limit test for leadlimit test for lead
limit test for lead
 
Assay of calcium gluconate
Assay of calcium gluconateAssay of calcium gluconate
Assay of calcium gluconate
 
Neutralization curves in acid base analytical titrations, indicators.
Neutralization curves in acid base analytical titrations, indicators.Neutralization curves in acid base analytical titrations, indicators.
Neutralization curves in acid base analytical titrations, indicators.
 
Analysis
AnalysisAnalysis
Analysis
 
Limit test for arsenic and lead
Limit test for arsenic and leadLimit test for arsenic and lead
Limit test for arsenic and lead
 
Anti dote
Anti doteAnti dote
Anti dote
 
Different Techniques of Pharmaceutical Analysis
Different Techniques of Pharmaceutical AnalysisDifferent Techniques of Pharmaceutical Analysis
Different Techniques of Pharmaceutical Analysis
 
UNIT I_History of pharmacopoeia and limit test
UNIT I_History of pharmacopoeia and limit testUNIT I_History of pharmacopoeia and limit test
UNIT I_History of pharmacopoeia and limit test
 
3.limit test for sulphate
3.limit test for sulphate3.limit test for sulphate
3.limit test for sulphate
 

Similar to History of Pharmacopoeia by Professor Beubenz

PHARMACOPOEIA
PHARMACOPOEIAPHARMACOPOEIA
PHARMACOPOEIA
TAUFIK MULLA
 
Indian pharmacopoeia
Indian pharmacopoeiaIndian pharmacopoeia
Indian pharmacopoeia
SRMUBarabanki
 
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit testsPharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
saimuniswetha1
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
shinganaarti
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
Prachi Pandey
 
Introduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptxIntroduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptx
RAHUL PAL
 
WHO guidelines for herbal drugs.pdf
WHO guidelines for herbal drugs.pdfWHO guidelines for herbal drugs.pdf
WHO guidelines for herbal drugs.pdf
Mayankpandey626786
 
Monograph ppt
Monograph pptMonograph ppt
CHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
CHAPTER I Pharmaceutics (History of pharmacy, PharmacopoeiaCHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
CHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
ThePharmacyWithADSir
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Ms. Pooja Bhandare
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Dr K SUDHEER KUMAR KANDIBANDA
 
Pharmaceutical analysis From Metrohm
Pharmaceutical analysis From MetrohmPharmaceutical analysis From Metrohm
Pharmaceutical analysis From Metrohm
Metrohm India Limited
 
Usp 2008track2combined
Usp 2008track2combinedUsp 2008track2combined
Usp 2008track2combined
Dr Prashant Bodhe
 
51 50-1-pb
51 50-1-pb51 50-1-pb
51 50-1-pb
sankrityayan
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipients
Hossen M. Faruk
 
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
ShaikhSaniya2
 
In detail - Indian Pharmacopoeia IP.pptx
In detail - Indian Pharmacopoeia IP.pptxIn detail - Indian Pharmacopoeia IP.pptx
In detail - Indian Pharmacopoeia IP.pptx
ushakiranmai4
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
SiddharthShekharSing4
 

Similar to History of Pharmacopoeia by Professor Beubenz (20)

PHARMACOPOEIA
PHARMACOPOEIAPHARMACOPOEIA
PHARMACOPOEIA
 
Indian pharmacopoeia
Indian pharmacopoeiaIndian pharmacopoeia
Indian pharmacopoeia
 
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit testsPharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
Pharmacopoeias,Sources of Impurities in Medicinal agents and Limit tests
 
Pharmacopoeia
PharmacopoeiaPharmacopoeia
Pharmacopoeia
 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
 
Introduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptxIntroduction to Pharmacy & Pharmaceutics.pptx
Introduction to Pharmacy & Pharmaceutics.pptx
 
B pharm syllabus pu
B pharm syllabus puB pharm syllabus pu
B pharm syllabus pu
 
WHO guidelines for herbal drugs.pdf
WHO guidelines for herbal drugs.pdfWHO guidelines for herbal drugs.pdf
WHO guidelines for herbal drugs.pdf
 
Monograph ppt
Monograph pptMonograph ppt
Monograph ppt
 
CHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
CHAPTER I Pharmaceutics (History of pharmacy, PharmacopoeiaCHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
CHAPTER I Pharmaceutics (History of pharmacy, Pharmacopoeia
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
 
Pharmaceutical analysis From Metrohm
Pharmaceutical analysis From MetrohmPharmaceutical analysis From Metrohm
Pharmaceutical analysis From Metrohm
 
Usp 2008track2combined
Usp 2008track2combinedUsp 2008track2combined
Usp 2008track2combined
 
51 50-1-pb
51 50-1-pb51 50-1-pb
51 50-1-pb
 
Pharmaceutical excipients
Pharmaceutical excipientsPharmaceutical excipients
Pharmaceutical excipients
 
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
Introduction to Pharmaceutical chemistry I first yr/D. pharmacy
 
In detail - Indian Pharmacopoeia IP.pptx
In detail - Indian Pharmacopoeia IP.pptxIn detail - Indian Pharmacopoeia IP.pptx
In detail - Indian Pharmacopoeia IP.pptx
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
 

Recently uploaded

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 

Recently uploaded (20)

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 

History of Pharmacopoeia by Professor Beubenz

  • 1. By… Mr. S. L. Khan M. Pharm(PhD), Assistant Professor, Pharmaceutical Chemistry, Rajarshi Shahu College of Pharmacy, Buldhana, Maharashtra Subscribe to the YouTube Channel #Professor_BeuBenz https://www.youtube.com/channel/UC84jGf2iRN5VjwnQqi6qmXg?view_as=subscriber
  • 2. Copyright © 2018 Professor BeuBenz INTRODUCTION Pharmacopoeia: the word derives from the ancient Greek word Pharmakon means Drug & Poeia means to make. It is a legally binding collection, prepared by a national or regional authority & contains list of medicinal substances, crude drug & formulas for making preparation from them. The pharmacopoeia contain-:  List of drug and other related substances  Sources  Description  Tests  Formulas for preparation actions  Uses  Doses  Storage conditions
  • 3. Copyright © 2018 Professor BeuBenz  National Pharmacopoeia(s): United States Pharmacopoeia (USP), Indian Pharmacopeia(IP), Pharmacopoeia of the People's Republic of China(PPRC), German Pharmacopeia, British Pharmacopoeia (BP), Portugese Pharmacopoeia, Mexican Pharmacopoeia, French Pharmacopoeia, Japanese Pharmacopoeia (JP) and Argentinean Pharmacopoeia  Regional Pharmacopoeia(s):  European Pharmacopoeia.  International Pharmacopoeia(s):  International Pharmacopoeia. Different Types of Pharmacopoeia
  • 4. Copyright © 2018 Professor BeuBenz INDIAN PHARMACOPOEIA  Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India The set of standards are published under the title Indian Pharmacopoeia (IP) Vision: The IPC is committed to the promotion of the highest standards for drugs for use in the prevention and treatment of diseases in human beings and animals keeping in view the special features of the pharmaceutical industry in India. Objectives…?
  • 5. Copyright © 2018 Professor BeuBenz HISTORY & EDITIONS The process of publishing the first Pharmacopoeia started in the year 1944 under the chairmanship of R. N. Chopra • In 1948 government of India appointed an Indian Pharmacopeia committee to prepare ‘Pharmacopeia of India’ • 1st edition I. P. 1955 was published in the official gazette. Dr. B. N. Ghosh, Chairman – Supplement 1960 • 2nd edition I. P. 1966, Dr. B. Mukherji, Chairman, Shankar S. – Supplement 1975 • 3rd edition I. P. 1985, Dr. Nityanand, Chairman – I Addendum/Supplement 1989 – II Addendum/Supplement 1991
  • 6. Copyright © 2018 Professor BeuBenz • 4th Edition I. P. 1996 Dr. Nityanand, Chairman – III Addendum/ Supplement 2000 – IV Addendum/ Supplement 2002 • 5th Edition I. P., 2007, Dr. Nityanand, Chairman • 6th Edition I. P., 2010 • 7th Edition I. P. 2014 -- V Addendum/Supplement 2015 • 8th Edition I. P. 2018 -- IV Volumes HISTORY & EDITIONS
  • 7. Copyright © 2018 Professor BeuBenz  The Indian Pharmacopoeia is the official book of standards and medicines produced in India must comply with the specified standards  Pharmacopoeial standards and acceptance criteria are set with the intention that they be used only as compliance requirements and not as requirements to guarantee total quality assurance  Pharmacopoeial standards are the minimum ones with which a manufacturer must comply before release of a product for sale or distribution  It is recognized that changes in quality may occur during storage and distribution and the pharmacopoeial requirements are set to define acceptable levels of change and to reject materials or products showing unacceptable levels OVERALL PHILOSOPHY
  • 8. Copyright © 2018 Professor BeuBenz It is the responsibility of the manufacturer to ensure that the product is manufactured in accordance with current Good Manufacturing Practices and that sufficiently stringent limits of acceptance are applied at the time of release of a batch of material or product so that the compendial standards are met until the expiry date under the storage conditions specified Pharmacopoeial requirements for drug substances have been drawn up to provide appropriate limits for potential impurities rather than to provide against all possible impurities and adulterants Material found to contain an impurity that cannot be detected by means of the prescribed tests is to be considered as not of pharmacopoeial quality if the nature or amount of the impurity found is not compatible with good manufacturing practices
  • 9. Copyright © 2018 Professor BeuBenz INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT Normal Format  Description. Physical form of the material, whether hygroscopic, odour, if apparent and indication of polymorphism, if applicable  Identification Tests usually including infrared spectrometry, if appropriate  Non-specific purity tests, such as light absorption, optical rotation, sulphated ash etc  Impurities , both related substances and impurities that may be present as a result of the method of manufacture or from degradation on storage  Impurities other than related substances that may require control such as heavy metals, inorganic impurities, residues of solvents and reagents used during synthesis and purification
  • 10. Copyright © 2018 Professor BeuBenz Other tests such as loss on drying or water Assay and limits for purity calculated on the anhydrous, dried or solvent-free basis, as appropriate To the extent possible, for assay, a robust and precise, though not specific method is given rather than a specific stability-indicating and complex one. With increasing emphasis on stability, the latter is often unavoidable In the case of non-specific assay methods, control of impurities is provided separately by means of specific impurity tests Each monograph is designed to be considered as a whole and should provide a reliable basis for judging the quality of the drug substance INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT
  • 11. Copyright © 2018 Professor BeuBenz